VIRAGEN ANNOUNCES ASIAN EXPANSION WITH SOUTH KOREAN MULTIFERON MARKETING AGREEMENT

A A

Viragen, Inc. today announced that it has entered into a license agreement with Kuhnil Pharm Co. Ltd., headquartered in Seoul, to distribute Multiferon(R) (multi-subtype, natural human alpha interferon) in South Korea. While financial terms were not disclosed, Viragen will receive a small up-front license fee in exchange for providing exclusive marketing rights to the drug in South Korea for a period of ten years.
PR Newswire